The artificial heart : prototypes, policies, and patients
著者
書誌事項
The artificial heart : prototypes, policies, and patients
National Academy Press, 1991
大学図書館所蔵 全4件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
"Support for this project was provided by the National Institutes of Health, National Heart, Lung, and Blood Institute, pursuant to contract no. NO1-HO-09008"--T.p. verso
Includes bibliographical references and index
内容説明・目次
内容説明
A significant medical event is expected in 1992: the first human use of a fully implantable, long-term cardiac assist device. This timely volume reviews the artificial heart program-and in particular, the National Institutes of Health's major investment-raising important questions.
The volume includes:
Consideration of the artificial heart versus heart transplantation and other approaches to treating end-stage heart disease, keeping in mind the different outcomes and costs of these treatments.
A look at human issues, including the number of people who may require the artificial heart, patient quality of life, and other ethical and societal questions.
Examination of how this technology's use can be targeted most appropriately.
Attention to achieving access to this technology for all those who can benefit from it.
The committee also offers three mechanisms to aid in allocating research and development funds.
Table of Contents
Front Matter
Executive Summary
1. The Artificial Heart Program: Current Status and History
2. Total Artificial Hearts: Technological Potential and Research
and Development Costs
3. Decisions for Future Research and Development
4. Clinical Effectiveness and Need for Long-Term Circulatory
Support
5. Quality of Life and Mechanical Circulatory Support Systems
6. Cost-Effectiveness Analysis
7. The Appropriate Use of Technology
8. Ethical and Societal Issues
9. Roles of Government and Industry in Medical Technology Research,
Development and Use
10. Conclusions and Recommendations
Appendix A: History and Methods of This Evaluation
Appendix B: A Chronology of the National Heart, Lung, and Blood
Institute Artificial Heart Program and Related Events
Appendix C: Technological Opportunities and Barriers in the
Development of Mechanical Circulatory Support Systems
Appendix D: Epidemiology of End-Stage Heart Disease
Appendix E: Assessing the Cost-Effectiveness of the Development and
Use of the Total Artificial Heart
Glossary
Index
目次
- 1 Front Matter
- 2 Executive Summary
- 3 1. The Artificial Heart Program: Current Status and History
- 4 2. Total Artificial Hearts: Technological Potential and Research and Development Costs
- 5 3. Decisions for Future Research and Development
- 6 4. Clinical Effectiveness and Need for Long-Term Circulatory Support
- 7 5. Quality of Life and Mechanical Circulatory Support Systems
- 8 6. Cost-Effectiveness Analysis
- 9 7. The Appropriate Use of Technology
- 10 8. Ethical and Societal Issues
- 11 9. Roles of Government and Industry in Medical Technology Research, Development and Use
- 12 10. Conclusions and Recommendations
- 13 Appendix A: History and Methods of This Evaluation
- 14 Appendix B: A Chronology of the National Heart, Lung, and Blood Institute Artificial Heart Program and Related Events
- 15 Appendix C: Technological Opportunities and Barriers in the Development of Mechanical Circulatory Support Systems
- 16 Appendix D: Epidemiology of End-Stage Heart Disease
- 17 Appendix E: Assessing the Cost-Effectiveness of the Development and Use of the Total Artificial Heart
- 18 Glossary
- 19 Index
「Nielsen BookData」 より